PL333464A1 - Application of phosphonic esters in treatment and prophylactics of cerebral functional disorders and depressions - Google Patents
Application of phosphonic esters in treatment and prophylactics of cerebral functional disorders and depressionsInfo
- Publication number
- PL333464A1 PL333464A1 PL97333464A PL33346497A PL333464A1 PL 333464 A1 PL333464 A1 PL 333464A1 PL 97333464 A PL97333464 A PL 97333464A PL 33346497 A PL33346497 A PL 33346497A PL 333464 A1 PL333464 A1 PL 333464A1
- Authority
- PL
- Poland
- Prior art keywords
- prophylactics
- depressions
- treatment
- application
- functional disorders
- Prior art date
Links
- 230000002490 cerebral effect Effects 0.000 title 1
- 150000002148 esters Chemical class 0.000 title 1
- 230000000069 prophylactic effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19616471A DE19616471A1 (de) | 1996-04-25 | 1996-04-25 | Phosponsäureester zur Behandlung von Hirnleistungsstörungen und Depressionen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL333464A1 true PL333464A1 (en) | 1999-12-20 |
Family
ID=7792381
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL97333464A PL333464A1 (en) | 1996-04-25 | 1997-04-17 | Application of phosphonic esters in treatment and prophylactics of cerebral functional disorders and depressions |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0896540A1 (xx) |
| JP (1) | JP2000510455A (xx) |
| KR (1) | KR20000010611A (xx) |
| AR (1) | AR006870A1 (xx) |
| AU (1) | AU2462397A (xx) |
| BG (1) | BG102864A (xx) |
| BR (1) | BR9709300A (xx) |
| CA (1) | CA2252567A1 (xx) |
| CZ (1) | CZ343498A3 (xx) |
| DE (1) | DE19616471A1 (xx) |
| HU (1) | HUP9903366A3 (xx) |
| ID (1) | ID16678A (xx) |
| IL (1) | IL126698A0 (xx) |
| NO (1) | NO984964L (xx) |
| PL (1) | PL333464A1 (xx) |
| SK (1) | SK146398A3 (xx) |
| TR (1) | TR199802137T2 (xx) |
| WO (1) | WO1997039756A1 (xx) |
| ZA (1) | ZA973538B (xx) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1078370B (de) * | 1958-09-16 | 1960-03-24 | Norddeutsche Affinerie | Schaedlingsbekaempfungsmittel |
| US3069312A (en) * | 1960-09-28 | 1962-12-18 | California Research Corp | N-substituted dimethyl 1-carbamoyloxy-2, 2, 2-trichloroethyl phosphonates as insecticidal compositions |
| BE632366A (xx) * | 1962-05-16 | 1900-01-01 | ||
| DE1193044B (de) * | 1963-08-05 | 1965-05-20 | Bayer Ag | Verfahren zur Herstellung phosphorylierter Urethane |
| DE2512375A1 (de) * | 1975-03-21 | 1976-09-30 | Bayer Ag | 1-hydroxy-2,2,2-trichloraethan- thionophosphonsaeuredialkylester, verfahren zu ihrer herstellung sowie ihre verwendung als insektizide |
| US4950658A (en) * | 1988-12-06 | 1990-08-21 | Board Of Trustees Of Southern Illinois Univ. | Method of medical treatment of Alzheimer's disease |
-
1996
- 1996-04-25 DE DE19616471A patent/DE19616471A1/de not_active Withdrawn
-
1997
- 1997-04-17 IL IL12669897A patent/IL126698A0/xx unknown
- 1997-04-17 HU HU9903366A patent/HUP9903366A3/hu unknown
- 1997-04-17 CA CA002252567A patent/CA2252567A1/en not_active Abandoned
- 1997-04-17 AU AU24623/97A patent/AU2462397A/en not_active Abandoned
- 1997-04-17 EP EP97920431A patent/EP0896540A1/en not_active Withdrawn
- 1997-04-17 TR TR1998/02137T patent/TR199802137T2/xx unknown
- 1997-04-17 BR BR9709300A patent/BR9709300A/pt not_active Application Discontinuation
- 1997-04-17 KR KR1019980708502A patent/KR20000010611A/ko not_active Application Discontinuation
- 1997-04-17 JP JP09538197A patent/JP2000510455A/ja active Pending
- 1997-04-17 WO PCT/US1997/006469 patent/WO1997039756A1/en not_active Application Discontinuation
- 1997-04-17 PL PL97333464A patent/PL333464A1/xx unknown
- 1997-04-17 SK SK1463-98A patent/SK146398A3/sk unknown
- 1997-04-17 CZ CZ983434A patent/CZ343498A3/cs unknown
- 1997-04-24 ID IDP971362A patent/ID16678A/id unknown
- 1997-04-24 ZA ZA9703538A patent/ZA973538B/xx unknown
- 1997-04-25 AR ARP970101724A patent/AR006870A1/es unknown
-
1998
- 1998-10-22 BG BG102864A patent/BG102864A/xx unknown
- 1998-10-23 NO NO984964A patent/NO984964L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO984964D0 (no) | 1998-10-23 |
| HUP9903366A3 (en) | 2000-08-28 |
| AU2462397A (en) | 1997-11-12 |
| KR20000010611A (ko) | 2000-02-25 |
| CZ343498A3 (cs) | 1999-02-17 |
| EP0896540A1 (en) | 1999-02-17 |
| NO984964L (no) | 1998-12-22 |
| BR9709300A (pt) | 1999-08-10 |
| TR199802137T2 (xx) | 1999-02-22 |
| WO1997039756A1 (en) | 1997-10-30 |
| JP2000510455A (ja) | 2000-08-15 |
| ID16678A (id) | 1997-10-30 |
| DE19616471A1 (de) | 1997-10-30 |
| IL126698A0 (en) | 1999-08-17 |
| CA2252567A1 (en) | 1997-10-30 |
| BG102864A (en) | 1999-09-30 |
| ZA973538B (en) | 1997-11-18 |
| HUP9903366A2 (en) | 2000-07-28 |
| SK146398A3 (en) | 1999-06-11 |
| AR006870A1 (es) | 1999-09-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP9800033A3 (en) | Compositions for the treatment of dermatological disorders and methods for their use | |
| EP0924983A4 (en) | S (-) - TOLTERODINE FOR THE TREATMENT OF URINARY AND GASTROINTESTINAL DISORDERS | |
| IL117229A0 (en) | Pyrazolopyrimidines and pyrrolopyrimidines for treatment of neuronal and other disorders | |
| EP0776210A4 (en) | METHOD FOR PROPHYLAXIS AND / OR TREATMENT OF PROLIFERATIVE AND / OR INFLAMMATORY CONDITIONS OF THE SKIN | |
| AU4775797A (en) | Process for the determination of app secretase modulators and the use thereof as agents in the treatment of alzheimer's disease | |
| PL330713A1 (en) | Spry-dried compositions of polymers and treatment methods | |
| IL121268A0 (en) | Branched chain fatty acids their derivatives and use in the treatment of central nervous system disorders | |
| EP0892632A4 (en) | AGENTS FOR USE IN PHOTOTHERAPEUTIC TREATMENT OF PROLIFERATIVE SKIN DISORDERS | |
| EP1011644A4 (en) | METHOD AND APPARATUS FOR THE TREATMENT OF PARKINSON'S DISEASE | |
| AU2466695A (en) | The use of famotidine and related compounds in the treatment of movement disorders | |
| AU3497097A (en) | Improved method for treatment and diagnosis of il-5 mediated disorders | |
| ZA951088B (en) | Use of substituted arylcyclobutylalkylamine compounds in the treatment of seizures neurological disorders and neurological damage | |
| GB2314273B (en) | The use of TCET in the prophylaxis and treatment of allergies | |
| PL332313A1 (en) | Application of benzopyranoles in treatment of neurological disorders | |
| GB9321341D0 (en) | Therapeutic compositions for use in the treatment of skin lesions and method of making same | |
| PL320922A1 (en) | Application of mhc-ii bonding and/or somulating molecules in prevention and/or treatment of diseases involving inflammatory processes | |
| PL333464A1 (en) | Application of phosphonic esters in treatment and prophylactics of cerebral functional disorders and depressions | |
| AU7602894A (en) | Use of 2-deoxycoformycin (pentostatin) for treating cerebral and cardiovascular disorders | |
| PL330797A1 (en) | Derivatives of piperidinacetic acid and their application in treating thrombotic disorders | |
| HUP9902802A3 (en) | Pyridyl- and pyrimidyl-piperazines in the treatment of substance abuse disorders | |
| EP0893123A4 (en) | MEANS OF PREVENTIVE AND CURATIVE TREATMENT OF CONDITIONS RELATED TO DIFFERENT FORMS OF AGING OF THE ORGANISM | |
| AU7622798A (en) | Application of thalidomide to the treatment of Parkinson's disease and Parkisonian syndromes | |
| HUP9701606A3 (en) | Use of sulbutiamine to obtain pharmaceutical compositions useful in the treatment of certain psychomotor and psychointellectual disorders | |
| AU9260198A (en) | Use of cycloalcane-phosphonic acid esters for treating mental disorders and depressions | |
| SI0833839T1 (en) | Peptidyl heterocycles useful in the treatment of thrombin related disorders |